Patents by Inventor Nicole Helbecque

Nicole Helbecque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for determining the susceptibility of a NIDDM patent toward sulfonylurea therapy
    Patent number: 6790618
    Abstract: A method is provided for determining the susceptibility of a NIDDM patient towards sulfonylurea therapy by obtaining a sample from a NIDDM patient where the sample includes nucleic acid molecules containing a fragment of the SUR1 gene comprising the nucleotide in position −3 of exon 16 and detecting the presence or absence of the −3 t allele in position −3 of exon 6 whereby the presence of at least one −3 t allele identifies a NIDDM patient with a high susceptibility towards sulfonylurea therapy.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: September 14, 2004
    Assignees: Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale (Inserm)
    Inventors: Philippe Amouyel, Nicole Helbecque, Aline Meirhaeghe
  • Method for determining the susceptibility of a NIDDM patient toward sulfonylurea therapy
    Publication number: 20030165944
    Abstract: A method is provided for determining the susceptibility of a NIDDM patient towards sulfonylurea therapy by obtaining a sample from a NIDDM patient where the sample includes nucleic acid molecules containing a fragment of the SUR1 gene comprising the nucleotide in position −3 of exon 16 and detecting the presence or absence of the −3t allele in position −3 of exon 16 whereby the presence of at least one −3t allele identifies a NIDDM patient with a high susceptibility towards sulfonylurea therapy.
    Type: Application
    Filed: December 6, 2002
    Publication date: September 4, 2003
    Inventors: Philippe Amouyel, Nicole Helbecque, Aline Meirhaeghe